Legal & General Group
ELV icon

Legal & General Group’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$713M Buy
1,833,099
+37,550
+2% +$14.6M 0.18% 105
2025
Q1
$781M Buy
1,795,549
+42,143
+2% +$18.3M 0.21% 88
2024
Q4
$647M Sell
1,753,406
-44,489
-2% -$16.4M 0.17% 104
2024
Q3
$935M Buy
1,797,895
+16,642
+0.9% +$8.65M 0.25% 69
2024
Q2
$965M Sell
1,781,253
-23,307
-1% -$12.6M 0.27% 61
2024
Q1
$936M Sell
1,804,560
-13,884
-0.8% -$7.2M 0.27% 66
2023
Q4
$858M Buy
1,818,444
+28,317
+2% +$13.4M 0.27% 64
2023
Q3
$779M Sell
1,790,127
-55,284
-3% -$24.1M 0.27% 63
2023
Q2
$820M Sell
1,845,411
-11,335
-0.6% -$5.04M 0.27% 66
2023
Q1
$854M Buy
1,856,746
+15,457
+0.8% +$7.11M 0.31% 58
2022
Q4
$945M Sell
1,841,289
-58,479
-3% -$30M 0.36% 48
2022
Q3
$863M Sell
1,899,768
-91,477
-5% -$41.6M 0.34% 52
2022
Q2
$961M Sell
1,991,245
-13,954
-0.7% -$6.73M 0.34% 52
2022
Q1
$985M Buy
2,005,199
+91,185
+5% +$44.8M 0.3% 61
2021
Q4
$887M Sell
1,914,014
-47,197
-2% -$21.9M 0.27% 70
2021
Q3
$731M Buy
1,961,211
+59,922
+3% +$22.3M 0.24% 84
2021
Q2
$726M Buy
1,901,289
+61,658
+3% +$23.5M 0.24% 82
2021
Q1
$660M Sell
1,839,631
-30,045
-2% -$10.8M 0.25% 80
2020
Q4
$600M Sell
1,869,676
-17,050
-0.9% -$5.47M 0.24% 82
2020
Q3
$507M Buy
1,886,726
+62,053
+3% +$16.7M 0.23% 83
2020
Q2
$480M Buy
1,824,673
+17
+0% +$4.47K 0.23% 80
2020
Q1
$415M Buy
1,824,656
+79,297
+5% +$18M 0.24% 80
2019
Q4
$527M Sell
1,745,359
-816
-0% -$246K 0.25% 78
2019
Q3
$419M Buy
1,746,175
+8,036
+0.5% +$1.93M 0.22% 94
2019
Q2
$490M Buy
1,738,139
+18,600
+1% +$5.25M 0.26% 75
2019
Q1
$493M Buy
1,719,539
+289,561
+20% +$83.1M 0.28% 71
2018
Q4
$376M Buy
1,429,978
+107,132
+8% +$28.1M 0.29% 72
2018
Q3
$363M Buy
1,322,846
+34,478
+3% +$9.45M 0.26% 81
2018
Q2
$307M Sell
1,288,368
-74,482
-5% -$17.7M 0.24% 86
2018
Q1
$299M Sell
1,362,850
-157,433
-10% -$34.6M 0.23% 93
2017
Q4
$342M Sell
1,520,283
-87,125
-5% -$19.6M 0.25% 87
2017
Q3
$305M Buy
1,607,408
+15,731
+1% +$2.99M 0.23% 97
2017
Q2
$299M Buy
1,591,677
+105,806
+7% +$19.9M 0.24% 94
2017
Q1
$246M Buy
1,485,871
+98,189
+7% +$16.2M 0.21% 109
2016
Q4
$200M Buy
1,387,682
+17,328
+1% +$2.49M 0.19% 130
2016
Q3
$172M Buy
1,370,354
+3,007
+0.2% +$377K 0.17% 139
2016
Q2
$180M Buy
1,367,347
+54,243
+4% +$7.12M 0.19% 124
2016
Q1
$182M Buy
1,313,104
+11,822
+0.9% +$1.64M 0.2% 115
2015
Q4
$181M Sell
1,301,282
-24,180
-2% -$3.37M 0.21% 114
2015
Q3
$186M Buy
1,325,462
+45,573
+4% +$6.38M 0.23% 103
2015
Q2
$210M Sell
1,279,889
-5,146
-0.4% -$845K 0.25% 95
2015
Q1
$198M Sell
1,285,035
-24,346
-2% -$3.76M 0.24% 97
2014
Q4
$165M Sell
1,309,381
-56,457
-4% -$7.1M 0.19% 124
2014
Q3
$163M Sell
1,365,838
-46,314
-3% -$5.54M 0.2% 123
2014
Q2
$152M Buy
1,412,152
+18,848
+1% +$2.03M 0.18% 134
2014
Q1
$139M Sell
1,393,304
-24,813
-2% -$2.47M 0.17% 145
2013
Q4
$131M Sell
1,418,117
-60,042
-4% -$5.55M 0.16% 150
2013
Q3
$124M Sell
1,478,159
-20,333
-1% -$1.7M 0.16% 147
2013
Q2
$123M Buy
+1,498,492
New +$123M 0.17% 140